1. Apoptosis Autophagy
  2. Apoptosis Autophagy
  3. Gracillin

Gracillin is a steroidal saponin that can be extracted from the roots of the plant and has anti-tumor properties. Gracillin can induce cancer cell apoptosis and autophagy.

For research use only. We do not sell to patients.

CAS No. : 19083-00-2

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
25 mg In-stock
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 2 publication(s) in Google Scholar

Other Forms of Gracillin:

Top Publications Citing Use of Products
Cell Proliferation/Viability Assay
WB
Apoptosis Analysis
Histological Imaging/Staining
In Vivo Efficacy Study

    Gracillin purchased from MedChemExpress. Usage Cited in: Bioorg Chem. 2025 May 29:163:108636.

    Cell viability was analyzed in human pancreatic duct (HPNE) and PDAC cells in response to Gracillin. Up to 4 μM, Gracillin did not exhibit cytotoxicity in HPNE cells, while significantly inhibiting PDAC cell viability.

    Gracillin purchased from MedChemExpress. Usage Cited in: Bioorg Chem. 2025 May 29:163:108636.

    Immunoblotting analysis confirmed reduced protein expression of PCNA in PDAC cells following Gracillin (0, 1, 2, 4 μM) treatment.

    Gracillin purchased from MedChemExpress. Usage Cited in: Bioorg Chem. 2025 May 29:163:108636.

    The apoptosis-inducing effects of Gracillin (0, 1, 2, 4 μM) were confirmed by Annexin V/PI staining in PDAC cells.

    Gracillin purchased from MedChemExpress. Usage Cited in: Bioorg Chem. 2025 May 29:163:108636.

    H&E and IHC performed on PANC-1 tumors demonstrating reduced NRF2, HO-1, PCNA, and BCL-2 expression and increased BAX expression following Gracillin treatment.

    Gracillin purchased from MedChemExpress. Usage Cited in: Bioorg Chem. 2025 May 29:163:108636.

    Tumor photograph showing the effects of vehicle, Gracillin (8 mg/kg, i.p.) and Gemcitabine treatments.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Gracillin is a steroidal saponin that can be extracted from the roots of the plant and has anti-tumor properties. Gracillin can induce cancer cell apoptosis and autophagy[1][2].

    Cellular Effect
    Cell Line Type Value Description References
    A2780 IC50
    4.3 μM
    Compound: Gracillin
    Cytotoxicity against human A2780 cells after 72 hrs by MTT assay
    Cytotoxicity against human A2780 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    A549 IC50
    0.96 μM
    Compound: Gracillin
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    BXPC-3 IC50
    1.3 μM
    Compound: Gracillin
    Cytotoxicity against human BxPC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human BxPC3 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    Bel-7402 IC50
    1.1 μM
    Compound: Gracillin
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    Capan-2 IC50
    1.3 μM
    Compound: Gracillin
    Cytotoxicity against human Capan2 cells after 72 hrs by MTT assay
    Cytotoxicity against human Capan2 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    HCT-8 IC50
    0.92 μM
    Compound: Gracillin
    Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    HL-60 IC50
    3.7 μM
    Compound: 9
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    [PMID: 12828464]
    HeLa IC50
    12.74 μg/mL
    Compound: 8
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
    [PMID: 15620239]
    MCF7 IC50
    17.5 μM
    Compound: Gracillin
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    PANC-1 IC50
    0.7 μM
    Compound: Gracillin
    Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay
    Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    SW1990 IC50
    1.1 μM
    Compound: Gracillin
    Cytotoxicity against human SW1990 cells after 72 hrs by MTT assay
    Cytotoxicity against human SW1990 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    In Vitro

    Gracillin (0-10 μM, 6-24 h) shows broad-spectrum inhibitory effects on the cancer cell viability[1].
    Gracillin (5 μM) disrupts mitochondrial function, specifically, inhibits ATP production, activates AMPK, inhibits oxygen consumption rate (OCR) ​in H460 and A549 cells[1].
    Gracillin (0-10 μM, 6 h) induces ROS generation (indicated by H2DCF-DA) ​in H460, H1299, H226B and A549 cells[1].
    Gracillin (0-4 μM, 24 h) blocks cell cycle in G1 phase, and induces apoptosis and autophagy in A549 cells[2][3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Apoptosis Analysis[2]

    Cell Line: A549 cells
    Concentration: 0-4 μM
    Incubation Time: 24 h
    Result: Induced morphological changes.
    Apoptosis rate: 6.56%-67.43%.
    In Vivo

    Gracillin (oral gavage, 10 mg/kg for xenografts and 20 mg/kg for PDX) inhibits tumor growth of xenograft tumors inoculating lung (H1299), prostate (DU145), and colorectum (HCT116) cancer cells, as well as patient-derived xenograft colon and lung tumors[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    885.04

    Formula

    C45H72O17

    CAS No.
    Appearance

    Solid

    Color

    White to light yellow

    SMILES

    C[C@@]12[C@]([C@@H]3C)([H])[C@](O[C@]34CC[C@@H](C)CO4)([H])C[C@@]1([H])[C@@](CC=C5[C@@]6(CC[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]7O[C@]([C@@H]([C@@H](O)[C@@H]8O)O)([H])O[C@@H]8CO)([H])[C@@H]7O[C@@](O[C@@H](C)[C@H](O)[C@H]9O)([H])[C@@H]9O)C5)C)([H])[C@]6([H])CC2

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    4°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    Solvent & Solubility
    In Vitro: 

    DMSO : 100 mg/mL (112.99 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.1299 mL 5.6495 mL 11.2989 mL
    5 mM 0.2260 mL 1.1299 mL 2.2598 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 2.08 mg/mL (2.35 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL Corn oil, and mix evenly.

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.91%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.1299 mL 5.6495 mL 11.2989 mL 28.2473 mL
    5 mM 0.2260 mL 1.1299 mL 2.2598 mL 5.6495 mL
    10 mM 0.1130 mL 0.5649 mL 1.1299 mL 2.8247 mL
    15 mM 0.0753 mL 0.3766 mL 0.7533 mL 1.8832 mL
    20 mM 0.0565 mL 0.2825 mL 0.5649 mL 1.4124 mL
    25 mM 0.0452 mL 0.2260 mL 0.4520 mL 1.1299 mL
    30 mM 0.0377 mL 0.1883 mL 0.3766 mL 0.9416 mL
    40 mM 0.0282 mL 0.1412 mL 0.2825 mL 0.7062 mL
    50 mM 0.0226 mL 0.1130 mL 0.2260 mL 0.5649 mL
    60 mM 0.0188 mL 0.0942 mL 0.1883 mL 0.4708 mL
    80 mM 0.0141 mL 0.0706 mL 0.1412 mL 0.3531 mL
    100 mM 0.0113 mL 0.0565 mL 0.1130 mL 0.2825 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Gracillin
    Cat. No.:
    HY-N0706
    Quantity:
    MCE Japan Authorized Agent: